These final results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 aid the strategy of targeting ACKR3 as a singular strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked disorders. The dietary supplement is https://mattw405yiy5.dgbloggers.com/profile